Related Experiment Video

Updated: Dec 20, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
10:25

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

5.1K

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Cuiqing Ma1, Shan Su2, Jiachao Wang1

  • 1Department of Immunology, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Hebei Medical University, 050017, Shijiazhuang, China.

Microbes and Infection
|May 22, 2020
PubMed

Insights

Developing vaccines against SARS-CoV-2 and other coronaviruses is crucial. Lessons from SARS-CoV vaccine development inform strategies for safe, effective, and broad-spectrum coronavirus vaccines.

Area of Science:

  • Virology
  • Immunology
  • Public Health

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, highlights the urgent need for effective vaccines.
  • SARS-CoV-2 shares genomic similarities and the ACE2 receptor with SARS-CoV, making prior vaccine research relevant.

Purpose of the Study:

  • To review the advantages and disadvantages of SARS-CoV vaccine candidates.
  • To identify strategies for developing safe, effective, and broad-spectrum coronavirus vaccines.

Main Methods:

  • Literature review of existing SARS-CoV vaccine research.
  • Analysis of SARS-CoV-2 and SARS-CoV genomic and receptor data.

Main Results:

  • Summary of current knowledge on SARS-CoV vaccine candidate efficacy and safety profiles.
  • Identification of key challenges and opportunities in coronavirus vaccine development.

Conclusions:

  • Leveraging SARS-CoV vaccine development experiences is essential for creating SARS-CoV-2 vaccines.
  • Future strategies should focus on broad-spectrum vaccines to combat current and emerging coronaviruses.
Keywords:
2019-nCoVCross-protectionHCoV-19SARS-CoVSARS-CoV-2Vaccine

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.3K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
32.7K
Vaccinations01:51

Vaccinations

Overview
50.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
663
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
25.7K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
9.6K